How do I subscribe to ongoing alerts?

Subscribe to /feed/company/irccs-azienda-ospedaliera-universitaria-san-martino-ist-istituto-nazionale-per-l.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy pipeline: 1 marketed, 0 filed, 2 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 2 Phase 3 0 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
albuterol plus tiotropium	albuterol plus tiotropium	marketed	Combination bronchodilator (SABA + LAMA)	Beta-2 adrenergic receptor (albuterol); M3 muscarinic receptor (tiotropium)	Respiratory/Pulmonology
Anastrozole or Letrozole or Exemestane	Anastrozole or Letrozole or Exemestane	phase 3	Aromatase inhibitor	Aromatase (CYP19A1)	Oncology
antidiabetics	antidiabetics	phase 3			Metabolic

Therapeutic area mix

Metabolic · 1
Oncology · 1
Respiratory/Pulmonology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

AstraZeneca · 1 shared drug class
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh · 1 shared drug class
Dharmais National Cancer Center Hospital · 1 shared drug class
Eastern Virginia Medical School · 1 shared drug class
Genor Biopharma Co., Ltd. · 1 shared drug class
Gynaecologisch Oncologisch Centrum Zuid · 1 shared drug class
IVI Madrid · 1 shared drug class
Amgen · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy:

Cite this brief

Drug Landscape (2026). IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/irccs-azienda-ospedaliera-universitaria-san-martino-ist-istituto-nazionale-per-l. Accessed 2026-05-17.